Royal Bank of Canada reaffirmed their outperform rating on shares of NICE (NASDAQ:NICE - Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $200.00 price target on the technology company's stock.
NICE has been the subject of a number of other reports. Rosenblatt Securities lowered their target price on shares of NICE from $225.00 to $200.00 and set a "buy" rating for the company in a research note on Friday, February 21st. Citigroup lowered their target price on shares of NICE from $279.00 to $228.00 and set a "buy" rating for the company in a research note on Monday, February 24th. Barclays decreased their price objective on NICE from $286.00 to $226.00 and set an "overweight" rating for the company in a report on Friday, February 21st. Cantor Fitzgerald decreased their price objective on NICE from $176.00 to $161.00 and set a "neutral" rating for the company in a report on Friday, February 21st. Finally, Jefferies Financial Group restated a "hold" rating and issued a $200.00 price objective (down from $215.00) on shares of NICE in a report on Thursday, December 19th. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $231.64.
Check Out Our Latest Analysis on NICE
NICE Stock Performance
NASDAQ NICE traded up $2.78 on Wednesday, hitting $156.78. 649,584 shares of the stock were exchanged, compared to its average volume of 565,960. The firm has a market capitalization of $9.86 billion, a P/E ratio of 23.19, a P/E/G ratio of 1.07 and a beta of 1.12. NICE has a 52-week low of $137.19 and a 52-week high of $270.73. The stock has a fifty day moving average price of $159.84 and a two-hundred day moving average price of $169.49.
NICE (NASDAQ:NICE - Get Free Report) last issued its earnings results on Thursday, February 20th. The technology company reported $2.25 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.96 by ($0.71). The company had revenue of $721.60 million for the quarter, compared to analysts' expectations of $718.47 million. NICE had a net margin of 16.18% and a return on equity of 16.17%. Sell-side analysts expect that NICE will post 9.85 earnings per share for the current fiscal year.
Institutional Investors Weigh In On NICE
A number of large investors have recently modified their holdings of the business. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of NICE during the fourth quarter worth about $313,808,000. Boston Partners grew its stake in shares of NICE by 10.0% during the fourth quarter. Boston Partners now owns 1,670,327 shares of the technology company's stock worth $283,349,000 after acquiring an additional 151,528 shares during the last quarter. Menora Mivtachim Holdings LTD. grew its stake in shares of NICE by 2.3% during the fourth quarter. Menora Mivtachim Holdings LTD. now owns 1,660,037 shares of the technology company's stock worth $281,941,000 after acquiring an additional 36,865 shares during the last quarter. HMI Capital Management L.P. grew its stake in shares of NICE by 12.8% during the fourth quarter. HMI Capital Management L.P. now owns 1,642,770 shares of the technology company's stock worth $279,008,000 after acquiring an additional 186,600 shares during the last quarter. Finally, CCLA Investment Management boosted its position in NICE by 14.1% in the fourth quarter. CCLA Investment Management now owns 704,494 shares of the technology company's stock valued at $119,517,000 after buying an additional 87,003 shares during the last quarter. Hedge funds and other institutional investors own 63.34% of the company's stock.
About NICE
(
Get Free Report)
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Read More
Before you consider NICE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.
While NICE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
